Your browser is no longer supported. Please, upgrade your browser.
Settings
PAVM [NASD]
PAVmed Inc.
Index- P/E- EPS (ttm)-0.74 Insider Own5.00% Shs Outstand82.46M Perf Week-4.60%
Market Cap369.77M Forward P/E- EPS next Y-0.28 Insider Trans-4.04% Shs Float72.01M Perf Month-25.98%
Income-34.60M PEG- EPS next Q-0.12 Inst Own11.00% Short Float7.17% Perf Quarter101.85%
Sales- P/S- EPS this Y-31.50% Inst Trans1.30% Short Ratio0.99 Perf Half Y139.56%
Book/sh-0.01 P/B- EPS next Y34.10% ROA-280.60% Target Price- Perf Year80.91%
Cash/sh0.21 P/C21.13 EPS next 5Y- ROE293.90% 52W Range1.63 - 6.59 Perf YTD105.66%
Dividend- P/FCF- EPS past 5Y-35.80% ROI- 52W High-33.84% Beta0.32
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low167.48% ATR0.47
Employees25 Current Ratio0.90 Sales Q/Q- Oper. Margin- RSI (14)45.39 Volatility10.30% 9.29%
OptionableYes Debt/Eq- EPS Q/Q12.70% Profit Margin- Rel Volume0.39 Prev Close4.46
ShortableYes LT Debt/Eq- EarningsFeb 22 AMC Payout- Avg Volume5.21M Price4.36
Recom2.00 SMA20-8.57% SMA50-4.42% SMA20059.57% Volume2,028,759 Change-2.24%
Mar-30-21Initiated Cantor Fitzgerald Overweight $8
Nov-05-20Initiated Ascendiant Capital Markets Buy $5
Jun-28-18Initiated Maxim Group Buy $5
May-06-21 09:30AM  
May-03-21 09:30AM  
Apr-29-21 09:30AM  
Apr-27-21 09:30AM  
Apr-15-21 09:30AM  
Apr-08-21 09:30AM  
Mar-10-21 09:30AM  
Mar-03-21 09:30AM  
Mar-01-21 09:30AM  
Feb-25-21 12:37PM  
Feb-23-21 09:00AM  
07:25AM  
Feb-22-21 04:13PM  
08:18AM  
Feb-18-21 09:30AM  
Feb-16-21 09:30AM  
Feb-11-21 08:30AM  
Feb-09-21 09:30AM  
Jan-08-21 10:53AM  
Jan-06-21 09:29AM  
Dec-22-20 12:04PM  
Dec-18-20 09:29AM  
Dec-16-20 02:53AM  
Dec-11-20 09:29AM  
Nov-30-20 09:15PM  
Nov-17-20 04:00PM  
02:45PM  
Nov-02-20 09:30AM  
Oct-06-20 07:30AM  
Sep-08-20 09:30AM  
Aug-27-20 09:30AM  
Aug-18-20 04:14PM  
Aug-06-20 09:27AM  
Aug-05-20 09:00AM  
Jul-28-20 09:30AM  
Jul-14-20 11:11PM  
Jul-13-20 09:30AM  
Jul-07-20 12:15PM  
Jun-17-20 09:30AM  
Jun-15-20 09:30AM  
07:30AM  
Jun-11-20 09:30AM  
Jun-03-20 09:30AM  
May-27-20 05:08PM  
May-21-20 04:00PM  
02:30PM  
May-11-20 09:30AM  
Apr-22-20 10:12AM  
Apr-21-20 09:30AM  
Apr-20-20 07:05PM  
Apr-09-20 04:44PM  
02:30PM  
Apr-02-20 09:30AM  
Mar-31-20 09:30AM  
Mar-24-20 09:30AM  
Mar-09-20 09:30AM  
Mar-02-20 09:30AM  
Feb-20-20 09:30AM  
Feb-18-20 09:30AM  
Feb-12-20 09:18AM  
Feb-11-20 09:30AM  
Jan-14-20 07:55AM  
Jan-13-20 09:30AM  
Dec-19-19 09:30AM  
Dec-16-19 06:16PM  
Dec-13-19 09:30AM  
Nov-29-19 10:37PM  
Nov-21-19 04:00PM  
Nov-14-19 09:30AM  
Nov-07-19 09:30AM  
Nov-06-19 09:30AM  
Nov-05-19 07:00AM  
Sep-20-19 05:43AM  
Sep-05-19 09:30AM  
Aug-21-19 09:30AM  
Aug-15-19 09:30AM  
Aug-07-19 09:30AM  
Jul-18-19 03:39PM  
Jun-26-19 09:30AM  
Jun-24-19 10:46AM  
Jun-13-19 09:18AM  
May-21-19 09:30AM  
May-20-19 09:30AM  
May-06-19 09:30AM  
Apr-24-19 09:30AM  
Apr-12-19 09:35AM  
Apr-04-19 12:25PM  
09:30AM  
Mar-21-19 07:30AM  
Mar-20-19 07:30AM  
Mar-13-19 08:04AM  
Feb-28-19 12:49PM  
Feb-26-19 07:30AM  
Jan-10-19 07:30AM  
Dec-17-18 07:00AM  
Nov-29-18 02:29PM  
07:30AM  
Nov-19-18 08:45AM  
Nov-15-18 07:30AM  
Nov-01-18 07:30AM  
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aklog LishanChairman and CEOMar 18Buy4.317,50032,3241,105,913Mar 19 01:07 PM
SIROVICH MATTHEW10% OwnerNov 25Sale1.9633,20365,0481,027,744Nov 27 03:07 PM
SIROVICH MATTHEW10% OwnerNov 24Sale2.0053,036105,8761,060,947Nov 27 03:07 PM
SIROVICH MATTHEW10% OwnerNov 19Sale1.8375,211137,4181,113,983Nov 20 01:01 PM
SIROVICH MATTHEW10% OwnerNov 18Sale1.7824,78944,1641,189,194Nov 20 01:01 PM
SIROVICH MATTHEW10% OwnerMay 29Sale1.98131,082259,4771,213,983Jun 01 01:18 PM
SIROVICH MATTHEW10% OwnerMay 28Sale2.0669,839143,6661,345,065Jun 01 01:18 PM